Invention Grant
US08440798B2 Generation of a cancer-specific immune response toward MUC1 and cancer specific MUC1 antibodies
有权
产生针对MUC1和癌症特异性MUC1抗体的癌症特异性免疫应答
- Patent Title: Generation of a cancer-specific immune response toward MUC1 and cancer specific MUC1 antibodies
- Patent Title (中): 产生针对MUC1和癌症特异性MUC1抗体的癌症特异性免疫应答
-
Application No.: US12444360Application Date: 2007-10-04
-
Publication No.: US08440798B2Publication Date: 2013-05-14
- Inventor: Henrik Clausen , Joy Burchell , Ulla Mandel , Anne Louise Sørensen , Mads Agervig Tarp , Joyce Taylor-Papadimitriou
- Applicant: Henrik Clausen , Joy Burchell , Ulla Mandel , Anne Louise Sørensen , Mads Agervig Tarp , Joyce Taylor-Papadimitriou
- Applicant Address: DK Copenhagen N GB London
- Assignee: Københavns Universitet,Cancer Research Technology Limited
- Current Assignee: Københavns Universitet,Cancer Research Technology Limited
- Current Assignee Address: DK Copenhagen N GB London
- Agency: Knobbe Martens Olson & Bear LLP
- International Application: PCT/DK2007/050139 WO 20071004
- International Announcement: WO2008/040362 WO 20080410
- Main IPC: C07K16/00
- IPC: C07K16/00
Abstract:
The present invention provides a method for inducing a cancer specific immune response against MUC1 using an immunogenic glycopeptide. Other aspects of the invention are a pharmaceutical composition comprising the immunogenic glycopeptide and a cancer vaccine comprising the immunogenic glycopeptide. Another aspect is an antibody generated using the immunogenic glycopeptide and the use of said antibody in therapy and diagnosis.
Public/Granted literature
- US20100034825A1 GENERATION OF A CANCER-SPECIFIC IMMUNE RESPONSE TOWARD MUC1 AND CANCER SPECIFIC MUC1 ANTIBODIES Public/Granted day:2010-02-11
Information query
